Pyruvate transamination and NAD biosynthesis enable proliferation of succinate dehydrogenase-deficient cells by supporting aerobic glycolysis
Cell Death & Disease · 2023
DOI: 10.1038/s41419-023-05927-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Death & Disease, 2023. Verfasst von Luisa Ricci und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Metabolism Unit, Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, 20132, Milan, Italy. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Associazione Italiana per la Ricerca sul Cancro, Ministero della Salute.
Abstract (Originalsprache)
Succinate dehydrogenase (SDH) is the mitochondrial enzyme converting succinate to fumarate in the tricarboxylic acid (TCA) cycle. SDH acts as a tumor suppressor with germline loss-of-function mutations in its encoding genes predisposing to aggressive familial neuroendocrine and renal cancer syndromes. Lack of SDH activity disrupts the TCA cycle, imposes Warburg-like bioenergetic features, and commits cells to rely on pyruvate carboxylation for anabolic needs. However, the spectrum of metabolic adaptations enabling SDH-deficient tumors to cope with a dysfunctional TCA cycle remains largely unresolved. By using previously characterized Sdhb -deleted kidney mouse cells, here we found that SDH deficiency commits cells to rely on mitochondrial glutamate-pyruvate transaminase (GPT2) activity for proliferation. We showed that GPT2-dependent alanine biosynthesis is crucial to sustain reductive carboxylation of glutamine, thereby circumventing the TCA cycle truncation determined by SDH loss. By driving the reductive TCA cycle anaplerosis, GPT2 activity fuels a metabolic circuit maintaining a favorable intracellular NAD + pool to enable glycolysis, thus meeting the energetic demands of SDH-deficient cells. As a metabolic syllogism, SDH deficiency confers sensitivity to NAD + depletion achieved by pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme of the NAD + salvage pathway. Beyond identifying an epistatic functional relationship between two metabolic genes in the control of SDH-deficient cell fitness, this study disclosed a metabolic strategy to increase the sensitivity of tumors to interventions limiting NAD availability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cancer Metabolism Unit, Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, 20132, Milan, Italy.
- CRUK Beatson Institute, Glasgow, UK.
- Cancer Metabolism Unit, Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, 20132, Milan, Italy. cardaci.simone@hsr.it.
ORCID-Profile: Luisa Ricci, Tanja Eberhart, David Sumpton, Simone Cardaci
Förderung
- Cancer Research UK
- Associazione Italiana per la Ricerca sul Cancro
- Ministero della Salute
Zitieren
APA
Ricci, L., Stanley, F. U., Eberhart, T., Mainini, F., Sumpton, D., & Cardaci, S. (2023). Pyruvate transamination and NAD biosynthesis enable proliferation of succinate dehydrogenase-deficient cells by supporting aerobic glycolysis. Cell Death & Disease. https://doi.org/10.1038/s41419-023-05927-5
Vancouver
Ricci L, Stanley FU, Eberhart T, Mainini F, Sumpton D, Cardaci S. Pyruvate transamination and NAD biosynthesis enable proliferation of succinate dehydrogenase-deficient cells by supporting aerobic glycolysis. Cell Death & Disease. 2023. doi:10.1038/s41419-023-05927-5
BibTeX
@article{Ricci2023,
author = {Ricci, Luisa and Stanley, Federico Uchenna and Eberhart, Tanja and Mainini, Francesco and Sumpton, David and Cardaci, Simone},
title = {Pyruvate transamination and NAD biosynthesis enable proliferation of succinate dehydrogenase-deficient cells by supporting aerobic glycolysis},
journal = {Cell Death & Disease},
year = {2023},
doi = {10.1038/s41419-023-05927-5}
}
EUVIMED